Literature DB >> 22691957

Putative episodes of T-cell-mediated rejection in patients with sustained BK viruria but no viremia.

Kosuke Masutani1, Ron Shapiro, Amit Basu, Henkie Tan, Toshiharu Ninomiya, Parmjeet Randhawa.   

Abstract

BACKGROUND: Polyomavirus BK (BKV) infection characterized by viruria alone is considered to be of little clinical significance, but this issue has not been systematically studied.
METHODS: We studied 230 patients with sustained viruria from whom multiple samples taken after a median of 877 days (range, 24-2739) showed no progression to viremia or nephropathy. Biopsies satisfying Banff thresholds for inflammation and tubulitis in the presence of viruria but negative for BKV stains were designated as putative T-cell-mediated acute rejection.
RESULTS: Compared with no viruria (n=515), sustained viruria was associated with more putative rejection episodes (0.62 vs. 0.33 per patient, P=0.006) and greater incidence of steroid resistance (36.2% vs. 19.6%, P=0.002). Most putative rejection episodes (52.1%) occurred concurrently with viruria, with a minority before (7.8%) or after (40.1%) BKV clearance. Steroid resistance was more frequent in putative rejection with concurrent viruria (48.6%), compared with rejection before (9.1%) or after (26.0%) viral clearance. These observations remained valid even on a separate analysis of patients with BKV load 1E+07 copies per mL or less. As assessed by the slope of reciprocal serum creatinine levels, accelerated deterioration of graft function resulted from rejection episodes occurring more than 2 years after transplantation.
CONCLUSIONS: These observations indicate that intrarenal viral replication in sustained viruria is frequently associated with putative acute rejection. The implications of this association on the development of immune tolerance deserve further investigation.

Entities:  

Mesh:

Year:  2012        PMID: 22691957      PMCID: PMC3391347          DOI: 10.1097/TP.0b013e318253e7a4

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  38 in total

1.  Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients.

Authors:  A Humar; K J Gillingham; W D Payne; D L Dunn; D E Sutherland; A J Matas
Journal:  Transplantation       Date:  1999-12-27       Impact factor: 4.939

2.  Tuberculosis associated immune reconstitution inflammatory syndrome.

Authors:  Sanjeev Sinha; S K Sharma
Journal:  Indian J Tuberc       Date:  2010-10

3.  Viral infection and renal transplant rejection.

Authors:  W T Morris
Journal:  Br Med J       Date:  1973-02-10

4.  Ganciclovir pharmacokinetics and cytokine dynamics in renal transplant recipients with cytomegalovirus infection.

Authors:  K M Tornatore; K W Garey; N Saigal; K Reed; B Murray; E Ingalls; R DiFrancesco; A Forrest; G Morse; R Venuto
Journal:  Clin Transplant       Date:  2001-10       Impact factor: 2.863

5.  Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients.

Authors:  Parmjeet Randhawa; Andrew Ho; Ron Shapiro; Abhay Vats; P Swalsky; Sydney Finkelstein; John Uhrmacher; Karen Weck
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

6.  Cytomegalovirus-induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells.

Authors:  J D Hosenpud; S W Chou; C R Wagner
Journal:  Transplantation       Date:  1991-11       Impact factor: 4.939

7.  Polyomavirus infection and acute vascular rejection in a kidney allograft: coincidence or mimicry?

Authors:  Ian D McGilvray; Ginette Lajoie; Atul Humar; Mark S Cattral
Journal:  Am J Transplant       Date:  2003-04       Impact factor: 8.086

8.  Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor.

Authors:  E Fietze; S Prösch; P Reinke; J Stein; W D Döcke; G Staffa; S Löning; S Devaux; F Emmrich; R von Baehr
Journal:  Transplantation       Date:  1994-09-27       Impact factor: 4.939

9.  Cytokine-mediated induction of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells.

Authors:  W J Waldman; D A Knight
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

10.  Human polyoma virus-associated interstitial nephritis in the allograft kidney.

Authors:  P S Randhawa; S Finkelstein; V Scantlebury; R Shapiro; C Vivas; M Jordan; M M Picken; A J Demetris
Journal:  Transplantation       Date:  1999-01-15       Impact factor: 4.939

View more
  6 in total

1.  Donor-derived Cell-free DNA and the Prediction of BK Virus-associated Nephropathy.

Authors:  Sam Kant; Jonathan Bromberg; Mark Haas; Daniel Brennan
Journal:  Transplant Direct       Date:  2020-10-23

2.  Intragraft Blood Dendritic Cell Antigen-1-Positive Myeloid Dendritic Cells Increase during BK Polyomavirus-Associated Nephropathy.

Authors:  Ünsal Yapici; Jesper Kers; Ivana Slavujevic-Letic; Geurt Stokman; Joris J T H Roelofs; Michiel C van Aalderen; Jaap W Groothoff; Onno J de Boer; Karlijn A M I van der Pant; Nike Claessen; Luuk B Hilbrands; Frederike J Bemelman; Ineke J M Ten Berge; Sandrine Florquin
Journal:  J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 10.121

Review 3.  Polyoma virus nephropathy in kidney transplantation.

Authors:  Jacob Rw Scadden; Adnan Sharif; Kassi Skordilis; Richard Borrows
Journal:  World J Transplant       Date:  2017-12-24

Review 4.  BK Virus-Associated Nephropathy after Renal Transplantation.

Authors:  Yasuhito Funahashi
Journal:  Pathogens       Date:  2021-02-02

5.  High-level viruria as a screening tool for BK virus nephropathy in renal transplant recipients.

Authors:  W James Chon; Nidhi Aggarwal; Masha Kocherginsky; Brenna Kane; Jozefa Sutor; Michelle A Josephson
Journal:  Kidney Res Clin Pract       Date:  2016-06-24

6.  Prognosis of BK polyomavirus nephropathy: 10-year analysis of 133 renal transplant recipients at a single center.

Authors:  Xu-Tao Chen; Shi-Cong Yang; Jun Li; Rong-Hai Deng; Wen-Fang Chen; Jiang Qiu; Li-Zhong Chen; Chang-Xi Wang; Gang Huang
Journal:  Chin Med J (Engl)       Date:  2019-02       Impact factor: 2.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.